Founded in 2002, Aseptic Technologies manufactures fill & finish solutions. Their core expertise lays in the innovation of aseptic filling processes for biopharmaceutical products, including the cell and gene therapy products. As a member of the SKAN Group since 2011, Aseptic Technologies leverage technological excellence of SKAN in the isolator design, providing integrated solutions for fill & finish projects, globally.

Aseptic Technologies develops, patents, manufactures and markets equipment that guarantees optimal aseptic assurance and complies with latest regulatory requirements, while simplifying the validation and operation processes in the safest way.

The AT-Closed Vial® Technology is one of the main innovations of Aseptic Technologies. It allows the filling of pre-sterilized vials to significantly reduce the risk of batch contamination while simplifying the fill and finish of the drug product.
They also manufacture other aseptic filling-related products, such as filling kits (AT-Filling Kit™) and aseptic connecting systems (AT-Connector™ System) used to transfer sterile liquids across separation walls.

Since 2015, SKAN and Aseptic Technologies have joined forces in the development of new platforms combining each company’s respective technologies with the aim of offering integrated solutions, fulfilling the future expectations of the industry.

Aseptic Technologies is ISO 9001 and ISO15378 certified.